Polarean Imaging PLC (LON:POLX)

Polarean Imaging PLC (LON:POLX)

Share Price
17.00 p
0 (0.00 %)
Market Cap
£17.24 m
Proactive Investors - Run By Investors For Investors

Polarean Imaging PLC RNS Release

Appointment of Chief Financial Officer

RNS Number : 2716X
Polarean Imaging PLC
29 April 2019

29 April 2019

Polarean Imaging Plc 

("Polarean" or the "Company")


Appointment of Chief Financial Officer


Polarean Imaging plc (AIM: POLX) Polarean Imaging plc (AIM: POLX), the clinical stage medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces the appointment of Charles (Chuck) Osborne, Jr as Chief Financial Officer (CFO) with immediate effect. Chuck Osborne's role is a non-board appointment.


Mr. Osborne joins the Company from Innocrin Pharmaceuticals Inc ("Innocrin"), a privately held oncology therapeutics company where he was CFO since 2015. Prior to his role at Innocrin, Mr. Osborne was CFO of Scynexis Inc, a publicly traded anti-infective company between 2003 and 2015.  Mr. Osborne holds a Bachelor of Science degree in Business Administration, with a Concentration in Accounting, from University of North Carolina. He is a Certified Public Accountant and began his accounting career at Deloittie & Touche in 1988. 


Mr. Osborne will replace the Company's current CFO Bill Patrick, who will stay with Polarean in the role of Financial Controller to Polarean Inc, the Company's wholly owned subsidiary. 


Richard Hullihen, CEO of Polarean Imaging, commented on the appointment: "We are delighted to welcome Chuck to Polarean's management team. Chuck's previous capital markets experience coupled with his knowledge of financial operations within the pharmaceutical industry will ensure strong leadership of the Company's financial function.


"On behalf of the Board, I would like to thank Bill Patrick for all his efforts and input to date both operationally and financially through the Company's admission to AIM last year and in the period since. Mr Patrick's involvement with the Company will continue with his new role of Financial Controller for Polarean Inc."


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.




Polarean Imaging plc

www.polarean.com / www.polarean-ir.com

Richard Hullihen, Chief Executive Officer

Via Walbrook PR

Richard Morgan, Chairman

SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)

Vadim Alexandre / Rob Rees (Corporate Broking)

Walbrook PR

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Anna Dunphy


Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Polarean Imaging PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use